Latest Business Expansion News

Adisyn Ltd has landed a A$14 million placement led by heavyweight institutional investors following two major graphene technology milestones in semiconductors and stealth drone materials.

Life360 has reported its first full year of profitability alongside a 32% revenue surge to $489.5 million in 2025, driven by user growth, new Pet GPS subscriptions, and a strategic advertising platform acquisition.

PARKD Limited reported a 37% revenue decline to $3.88 million for H1 FY2026, driven by the winding down of its flagship Audi Centre Myaree project. The company posted a $1.03 million loss as it invests in East Coast growth and commissions a new prefabrication facility in Penrith, NSW.

TPG Telecom reported a robust FY25 with strategic asset sales, a major network sharing deal, and a $3 billion capital return, underpinning strong financial and sustainability progress.

Carma Limited delivered a robust H1 FY26 performance with a 102% surge in gross profit, driven by strong unit growth and strategic expansion of its Sell-to Carma locations and reconditioning capacity.

Ovanti Limited has completed a $1.08 million capital raise through a large share placement aimed at funding its growing U.S. buy now, pay later business and global operations.

AuMake Limited reports positive operating cashflow and a strategic pivot into China’s high-growth OTC medicine market, supported by a $1.5 million capital raise and significant governance reforms.

Synertec Corporation Limited has reported a robust 25% increase in revenue for FY26 Q2 alongside a significant turnaround to positive operating cashflow, underpinned by strong project pipelines and strategic partnerships.

Ovanti Limited has completed a $1 million capital raise through a discounted share placement to accelerate its buy now, pay later business expansion in the United States.

AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Novatti Group has attracted a $1 million investment from Australian Wealth Advisors Group to fuel its renewed growth strategy, focusing on expanding its Acquiring business following positive early financial results.